Fig. 3From: Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory responseAPP overexpression does not affect gut microbiome diversity prior to amyloid onset. Analysis of gut microbiome from stool samples collected at 6 wk of age while half of each genotype was still receiving dox chow, focusing on the effect of genotype. A, B Graphs of observed OTUs (A) and Simpson index (B) reveal that genotype had no effect on α-diversity at this age. Both measures were similar across genotypes whether APP overexpression was active (in untreated Tg mice) or not (with dox suppression). C, D PCoA plots of weighted UniFrac distances indicate that genotype did not affect β-diversity in untreated (C) or dox-treated mice (D). E The relative abundance of bacterial taxa is similar between genotypes at 6 wk of age for both treatment conditions. Statistical testing: Kruskal–Wallis (A, B), PERMANOVA (C, D), and Mann–Whitney U (E). n = 5–7 mice/group. Red and blue = dox-treated Tg and WT, respectively; grey and white = untreated Tg and WT, respectivelyBack to article page